Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A monoclonal antibody against interleukin-12 and interleukin-23 has been approved by the FDA for the treatment of plaque psoriasis. Ustekinumab is marketed as a subcutaneous injection by Centocor Ortho Biotech as Stelara™.

Pharmacology Update: Ustekinumab Injection (Stelara™)